This could be an opportunity to bring to the FDA our concerns regarding the use of neonatal foreskins in the development of cosmetic and medical products, particularly in the light of increased risks to male infants from community acquired MRSA, new research on the harm to sexual health caused by circumcision and the availability of alternatives (as used in Europe and around the rest of the world).
I'll start work on a response document over the weekend.
SUMMARY: In accordance with Executive Order 13563, ``Improving
Regulation and Regulatory Review,'' the Food and Drug Administration
(FDA) is conducting a review of its existing regulations to determine,
in part, whether they can be made more effective in light of current
public health needs and to take advantage of and support advances in
innovation. The goal of this review of existing regulations, as with
our other reviews, is to help ensure that FDA's regulatory program is
more effective and less burdensome in achieving its regulatory
objectives. FDA is requesting comment and supporting data on which, if
any, of its existing rules are outmoded, ineffective, insufficient, or
excessively burdensome and thus may be good candidates to be modified,
streamlined, expanded, or repealed. As part of this review, FDA also
invites comment to help us review our framework for periodically
analyzing existing rules.